Lutherville-Timonium

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Heart failure1 trial
• Melanoma1 trial
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Not yet recruiting2 trials
• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• AstraZeneca5 trials

Running trials

• Recruiting

  A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

  NCT07619131· Phase 3· AstraZeneca· Source

• Recruiting

  A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  NCT07662109· Phase 3· AstraZeneca· Source

• Recruiting

  Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  NCT06677060· Phase 3· AstraZeneca· Source

• Active, not recruiting

  A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition

  NCT05061134· Phase 2· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

  NCT06595238· Phase 2· AstraZeneca· Source